An endogenous retroviral long terminal repeat at the HLA-DQB1 gene locus confers susceptibility to rheumatoid arthritis

Human Immunology

Volumn 60, Issue 1, 1999, Pages 63-68

  Seidl, Christian ^a   Donner, Horst ^b   Petershofen, Eduard ^a   Usadel, Klaus Henning ^b   Seifried, Erhard ^a   Kaltwasser, Joachim Peter ^b   Badenhoop, Klaus ^a  

^a Inst Transfus Med I   (Germany)

^b Centre of Internal Medicine   (Germany)

Author keywords

DQ; Endogenous retrovirus; Genetics; HLA; LTR

Indexed keywords

HLA DQ ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0032954251     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00095-0     Document Type: Article

References (34)

1. Leib-Mösch C., Haltmeier M., Werner T., Geigl E.M., Brack-Werner R., Francke U., Erfle V., Hehlmann R. Genomic distribution and transcription of solitary HERV-K LTRs. Genomics. 18:1993;261-269.
2. Löwer R., Löwer J., Kurth R. The virus in all of us characteristics and biological significance of human endogenous retrovirus sequences . Proc Natl Acad Sci USA. 93:1996;5177-5184.
3. Leib-Mösch C., Seifarth W. Evolution and biological significance of human retroelements. Virus genes. 11:1996;133-145.
4. Urnovitz H.B., Murphy W.H. Human endogenous retroviruses Nature, occurence and clinical implications in human disease . Clin Microbiol Rev. 9:1996;72-99.
5. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis an approach to understand the molecular genetics of susceptibility to rheumatoid arthritis . Arthritis Rheum. 30:1987;1205-1213.
6. Deighton C.M., Cavanagh G., Rigby A.S., Lloyd H.L., Walker D.J. Both inherited HLA-haplotypes are important in the predisposition to rheumatoid arthritis. Br J Rheumatol. 32:1993;893-898.
7. Toda Y., Minamikawa Y., Akagi S., Sugano H., Mori Y., Nishimura H., Arita S., Sugino Y., Ogawa R. Rheumatoid-susceptible alleles of HLA-DRB1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA. Ann Rheum Dis. 53:1994;587-592.
8. Seidl C., Koch U., Buhleier T., Frank R., Möller B., Markert E., Koller-Wagner G., Seifried E., Kaltwasser J.P. HLA-DRB1*04 subtypes are associated with increased inflammatory activity in early rheumatoid arthritis. Br J Rheumatol. 36:1997;941-944.
9. Weyand C.M., Goronzy J.J. Disease mechanisms in rheumatoid arthritis Gene dosage effect of HLA-DR haplotypes . J Lab Clin Med. 124:1994;335-338.
10. Lanchbury J.S.S., Sakkas L.I., Marsh S.G.E., Bodmer J.G., Welsh K.I., Panayi G.S. HLA-DQb 3 1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis . Hum Immunol. 26:1989;59-71.
11. Hillarby M.C., Clarkson R., Greennan D.M., Bate A.S., Ollier W., Sanders P.A., Chattophadhyay C., Davis M., O'Sullivan M.M., Williams B. Immunogenetic heterogeneity in rheumatoid disease as illustrated by different MHC associations (DQ, Dw and C4) in articular and extra-articular subsets. Br J Rheumatol. 30:1991;5-9.
12. Sansom D.M., Amin S.N., Biswell J.L., Klouda P.T., Bradley B.A., Evison G., Goulding N.J., Hall N.D., Maddison P.J. HLA-DQ-related restriction fragment length polymorphism in rheumatoid arthritis evidence for a link with disease expression . Br J Rheumatol. 28:1989;374-378.
13. Sansom D.M., Bidwell J.L., Maddison P.J., Campion G., Klouda P.T., Bradley B.A. HLA-DQα and DQβ restriction fragment length polymorphisms associated with Felty's syndrome and DR4 positive rheumatoid arthritis. Hum Immunol. 19:1987;269-278.
14. So A.K.L., Warner C.A., Sansom D., Walport M.J. DQβ polymorphism and genetic susceptibility to Felty's syndrome. Arthritis Rheum. 31:1988;990-994.
15. Zanelli E., Krco C.J., Baisch J.M., Cheng S., David C.S. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci USA. 93:1996;1814-1819.
16. Zanelli E., Krco C.J., David C.S. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity Implications for rheumatoid arthritis predisposition . J Immunol. 158:1997;3545-3551.
17. Lee JS: in Dupont B (ed): Immunobiology of HLA. New York, Springer Vol 2, pp 49-61, 1989.
18. Kambhu S., Falldorf P., Lee J.S. Endogenous retroviral long terminal repeats within the HLA-DQ locus. Proc Natl Acad Sci USA. 87:1990;4927-4931.
19. Badenhoop K., Tönjes R.R., Rau H., Donner H., Rieker W., Braun J., Herwig J., Mytilineos J., Kurth R., Usadel K.H. Endogenous retroviral long terminal repeats of the HLA DQB1 gene are associated with susceptibility to type I diabetes mellitus (IDDM). Hum Immunol. 50:1996;103-110.
20. Bein G., Gläser R., Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens. 39:1992;68-73.
21. Svejgaard A., Ryder L.P. HLA and disease association detecting the strongest association . Tissue Antigens. 43:1994;18-27.
22. Epplen C., Santoa E.J.M., Guerreiro J.F., van Helden P., Epplen J.T. Coding versus intron variability extremely polymorphic HLA-DRB1 exons are flanked by specific composite microsattellites, even in distant populations . Hum Genet. 99:1997;399-406.
23. Svensson A.-C., Andersson G. Presence of retroelements reveal the evolutionary history of the human DR haplotypes. Hereditas. 127:1997;113-124.
24. She J.-X. Susceptibility to type I diabetes HLA-DQ and DR revisited . Immunol Today. 17:1996;323-329.
25. Akerblom I.E., Slater E.P., Beato M., Baxter J.D., Mellon P.L. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science. 241:1988;350-353.
26. Sauter M., Schommer S., Kremmer E., Remberger K., Dölken G., Lemm I., Buck M., Best B., Neumann-Haefelin D., Mueller-Lantzsch N. Human endogenous retrovirus K10 expression of Gag protein and detection of antibodies in patients with seminomas . J Virol. 69:1995;414-421.
27. Löwer R., Boller K., Hasenmaier B., Korbmacher C., Mueller Lantzsch N., Löwer J., Kurth R. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci USA. 90:1993;4480-4484.
28. Wu J., Zhou T., He J., Mountz J.D. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med. 178:1993;461-468.
29. Acha-Orbea H., Palmer E. Mls - a retrovirus exploits the immune system. Immunol Today. 12:1991;356-361.
30. Conrad B., Weismahr R.N., Böni J., Arcari R., Schüpbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell. 90:1997;303-313.
31. Perron H., Garson J.A., Bedin F., Beseme F., Paranhos-Baccala G., Komurian-Pradel F., Mallet F., Tuke P.W., Voisset C., Blond J.L., Lalande B., Seigneurin J.M., Mandrand B. molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA. 94:1997;7583-7588.
32. La Mantia G., Majello B., Di Cristofano A., Strazzullo M., Minchiotti G., Lania L. Identification of regulatory elements within the minimal promoter region of the human endogenous ERV9 provirus accurate transcription initiation is controlled by Inr-like element . Nucleid Acids Res. 20:1992;4129-4136.
33. Tassabehji M., Strachan T., Anderson M., Campbell R.D., Collier S., Lako M. Identification of a novel family of human endogenous retroviruses and characterization of one family member, HERV-K(4) located in the complement C4 cluster. Nucleid Acids Res. 22:1994;5211-5217.
34. Zhu Z.B., Hsieh S.L., Bentley D.R., Campbell R.D., Volanakis J.E. A variable number of tandem repeat locus within the human complement C2 gene is associated with a retroposon derived from a endogenous retrovirus. J Exp Med. 175:1992;1783-1787.